NPI: 1518929280 · PHILADELPHIA, PA 19147 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/06/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/06/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,692 | $11K |
| 2019 | 267 | $0.00 |
| 2020 | 1,357 | $137K |
| 2021 | 5,909 | $603K |
| 2022 | 6,670 | $599K |
| 2023 | 5,737 | $658K |
| 2024 | 4,118 | $555K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 21,764 | 1,880 | $2.55M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 5,468 | 352 | $11K |
| A4657 | Syringe, with or without needle, each | 1,316 | 646 | $101.70 |
| 83540 | 209 | 187 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 2,235 | 551 | $0.00 |
| 83970 | 313 | 274 | $0.00 | |
| 85048 | 352 | 326 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 544 | 301 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 143 | 12 | $0.00 |
| 85041 | 352 | 326 | $0.00 | |
| 82108 | 20 | 19 | $0.00 | |
| 83550 | 209 | 187 | $0.00 | |
| 82728 | 178 | 159 | $0.00 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 2,271 | 217 | $0.00 |
| 82607 | 18 | 18 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 105 | 102 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 92 | 86 | $0.00 |
| 82746 | 17 | 17 | $0.00 | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 144 | 14 | $0.00 |